The JAK inhibitor tofacitinib for active rheumatoid arthritis: Results from Phase III trials

  1. Salgado, E.
  2. Gómez-Reino, J.J.
Journal:
International Journal of Clinical Rheumatology

ISSN: 1758-4272 1758-4280

Year of publication: 2013

Volume: 8

Issue: 3

Pages: 315-326

Type: Article

DOI: 10.2217/IJR.13.26 GOOGLE SCHOLAR